Table 3.
Relationship between the expression levels of the top 10 lncRNAs and clinicopathological features of PTC based on TCGA data
Age | Gender | Histological type | Recurrence | Tumor size | Lymph node | TNM stage | Distant metastasis | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Z | P | Z | P | Z | P | Z | P | Z | P | Z | P | Z | P | Z | P | |
CTD‐2008L172 | 0.24 | 0.813 | 1.23 | 0.220 | 2.10 | 0.036 | −1.01 | 0.314 | −2.84 | 0.005 | −2.72 | 0.007 | −2.51 | 0.012 | −0.06 | 0.954 |
HAGLROS | 1.96 | 0.050 | 1.38 | 0.166 | −2.24 | 0.025 | 1.28 | 0.199 | 0.46 | 0.647 | 0.71 | 0.475 | 1.68 | 0.092 | 1.45 | 0.147 |
AC0936091 | −0.50 | 0.616 | 0.35 | 0.723 | −2.23 | 0.025 | −1.81 | 0.070 | −1.18 | 0.239 | 1.19 | 0.235 | 0.46 | 0.645 | −2.06 | 0.040 |
LINC01354 | 0.08 | 0.933 | −1.72 | 0.085 | 0.74 | 0.459 | −2.08 | 0.037 | −0.47 | 0.642 | −0.81 | 0.415 | −1.38 | 0.167 | −2.48 | 0.013 |
RP11‐547D24.1 | −0.52 | 0.600 | 2.67 | 0.008 | 1.90 | 0.058 | −0.83 | 0.407 | −2.91 | 0.004 | −2.36 | 0.018 | −3.57 | 0.000 | −1.06 | 0.289 |
UNC5B‐AS1 | 0.64 | 0.524 | 1.13 | 0.258 | −2.25 | 0.024 | 0.95 | 0.340 | 1.95 | 0.052 | 1.53 | 0.125 | 2.16 | 0.031 | 2.56 | 0.010 |
RP11‐363E74 | −2.49 | 0.013 | 2.43 | 0.015 | −1.72 | 0.086 | 1.30 | 0.192 | 0.40 | 0.686 | 0.08 | 0.933 | −0.78 | 0.436 | 0.79 | 0.432 |
LINC01977 | −1.87 | 0.062 | 1.70 | 0.088 | −0.56 | 0.573 | 1.71 | 0.087 | −0.12 | 0.906 | 0.71 | 0.480 | 0.07 | 0.941 | 2.19 | 0.028 |
RUNDC3A‐AS1 | 0.24 | 0.813 | 0.56 | 0.575 | 2.65 | 0.008 | 1.90 | 0.058 | −0.58 | 0.560 | −2.18 | 0.029 | 0.01 | 0.992 | 1.40 | 0.161 |
RP3‐483K164 | −0.31 | 0.759 | −0.08 | 0.937 | 1.23 | 0.22 | −1.18 | 0.237 | −3.09 | 0.002 | −2.51 | 0.012 | −1.92 | 0.055 | 0.30 | 0.765 |
lncRNAs, Long noncoding RNAs; PTC, papillary thyroid carcinoma; TCGA, The Cancer Genome Atlas.